Dashboard
Manage Tickers

SCPH scPharmaceuticals Inc.

Nasdaq scpharmaceuticals.com


$ 5.67 $ 0.00 (0 %)    

Monday, 06-Oct-2025 16:00:00 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.28 $ 6.52 (1.07 %)
DIA $ 472.51 $ 4.92 (1.05 %)
SPY $ 677.14 $ 5.49 (0.82 %)
TLT $ 91.45 $ 0.04 (0.04 %)
GLD $ 378.37 $ -1.27 (-0.34 %)
$ 5.67
$ 5.68
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 1.94 - $ 6.28
10,898,632
na
302.2M
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-19-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-13-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-22-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-22-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-23-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-24-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 03-21-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-07-2018 03-31-2018 10-Q
31 03-21-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

craig-hallum-downgrades-scpharmaceuticals-to-hold-announces-6-price-target
Craig-Hallum Downgrades scPharmaceuticals ...
08/26/2025 18:01:14

Craig-Hallum analyst Chase Knickerbocker downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold and announces $6 price ...

maxim-group-downgrades-scpharmaceuticals-to-hold
Maxim Group Downgrades scPharmaceuticals t...
08/25/2025 18:57:36

Maxim Group analyst Naz Rahman downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold.

mannkind-backed-by-blackstone-expands-cardiorenal-focus-with-360-million-deal
MannKind, Backed By Blackstone, Expands Ca...
08/25/2025 17:57:32

MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a ...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/25/2025 12:08:04

trading-halt-halt-status-updated-at-75500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:55:...
08/25/2025 11:55:14

Core News & Articles
MannKind To Acquire scPharmaceuticals For ...
08/25/2025 11:33:57

trading-halt-halted-at-72500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:25:00 a.m. ET - ...
08/25/2025 11:25:06

scpharmaceuticals-secures-5-new-uspto-patent-allowances-for-scp-111-furosemide-formulation-ahead-of-supplemental-nda-filing
scPharmaceuticals Secures 5 New USPTO Pate...
08/14/2025 12:41:28

scPharmaceuticals Inc. (NASDAQ:SCPH) (the "Company"), a pharmaceutical company committed to revolutionizing cardiorenal...

scpharmaceuticals-q2-eps-034-misses-030-estimate-sales-16041m-beat-15413m-estimate
scPharmaceuticals Q2 EPS $(0.34) Misses $(...
08/07/2025 20:04:28

scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

scpharmaceuticals-q1-eps-037-misses-030-estimate-sales-1175m-beat-1163m-estimate
scPharmaceuticals Q1 EPS $(0.37) Misses $(...
05/14/2025 20:04:54

scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For May 14, 2025
05/14/2025 08:32:23

insights-ahead-scpharmaceuticalss-quarterly-earnings
Insights Ahead: scPharmaceuticals's Quarte...
05/13/2025 19:04:01

analyst-expectations-for-scpharmaceuticalss-future
Analyst Expectations For scPharmaceuticals...
03/20/2025 20:00:33

maxim-group-maintains-buy-on-scpharmaceuticals-lowers-price-target-to-12
Maxim Group Maintains Buy on scPharmaceuti...
03/20/2025 14:59:46

Maxim Group analyst Naz Rahman maintains scPharmaceuticals (NASDAQ:SCPH) with a Buy and lowers the price target from $20 to ...

hc-wainwright--co-reiterates-buy-on-scpharmaceuticals-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on scPh...
03/20/2025 10:15:00

HC Wainwright & Co. analyst Douglas Tsao reiterates scPharmaceuticals (NASDAQ:SCPH) with a Buy and maintains $18 price t...

scpharmaceuticals-q4-2024-gaap-eps-035-beats-038-estimate-sales-1220m-beat-1208m-estimate
scPharmaceuticals Q4 2024 GAAP EPS $(0.35)...
03/19/2025 20:03:20

scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0...

earnings-scheduled-for-march-19-2025
Earnings Scheduled For March 19, 2025
03/19/2025 08:32:11

hc-wainwright--co-reiterates-buy-on-scpharmaceuticals-maintains-18-price-target
HC Wainwright & Co. Reiterates Buy on scPh...
03/07/2025 12:15:00

HC Wainwright & Co. analyst Douglas Tsao reiterates scPharmaceuticals (NASDAQ:SCPH) with a Buy and maintains $18 price t...

scpharmaceuticals-announces-fda-approval-for-supplemental-new-drug-application-expanding-furoscix-indication-to-include-treatment-of-edema-in-patients-with-chronic-kidney-disease
scPharmaceuticals Announces FDA Approval F...
03/06/2025 21:03:01

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION